StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron (REGN) Resumes Trading Up 1%
June 9, 2015 6:50 PM
Regeneron (NASDAQ: REGN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Hot FDA News
Trader Talk
Trading Halts
Next Articles
AdCom Approval, Reservations on Praluent Largely Inline with Expectations; Roth Affirms Regeneron (REGN) at 'Neutral'
June 10, 2015 7:54 AM
Regeneron (REGN) PRALUEN Panel Commentary Could Result in Narrower-Than-Expected Labeling, BMO Capital Says
June 10, 2015 7:48 AM
FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia
June 9, 2015 6:40 PM
Regeneron (REGN) to Resume Trading at 6:50PM ET
June 9, 2015 6:36 PM
Regeneron (REGN) Confirms FDA Panel Backing of Praluent
June 9, 2015 6:34 PM
FDA Advisory Committee Recommends Approval of Regeneron and Sanofi's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia
June 9, 2015 6:30 PM
After-Hours Stock Movers 06/09: (REGN) (CTIC) (SIGM) HIGHER; (SALT) (RXDX) (HRTX) LOWER (more...)
June 9, 2015 6:05 PM
Esperion (ESPR), Amgen (AMGN) Shares Weaken Post-Market After Praluent Gets FDA Backing
June 9, 2015 5:39 PM
Regeneron (REGN) and Sanofi's (SNY) Praluent Wins FDA Panel Backing - Bloomberg
June 9, 2015 4:52 PM
Trading in Regeneron Common Stock Halted
June 9, 2015 7:05 AM
Regeneron (REGN) Halted Ahead of FDA Panel Review of Praluent
June 9, 2015 6:56 AM
